Preliminary safety data from a randomized multicenter phase Ib/II study of neoadjuvant chemoradiation therapy (CRT) alone or in combination with pembrolizumab in patients with resectable or borderline resectable pancreatic cancer.

被引：16
作者：
Katz, Matthew H. G.
Varadhachary, Gauri R.
Bauer, Todd W.
Acquavella, Nicolas
Merchant, Nipun B.
Le, Tri Minh
Javle, Milind M.
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.4125
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4125
引用
收藏
页数：5
相关论文
共 50 条
  • [11] The Role of Neoadjuvant Chemoradiation Therapy in Patients With Borderline Resectable Pancreatic Cancer With Isolated Venous Vascular Involvement
    Lee, Jin Ho
    Kang, Chang Moo
    Bang, Seung Min
    Choi, Jin Young
    Seong, Jin Sil
    Hwang, Ho Kyoung
    Choi, Sung Hoon
    Lee, Woo Jung
    MEDICINE, 2015, 94 (31)
  • [12] Phase II study of neoadjuvant chemotherapy with modified FOLFOXIRI in borderline resectable or unresectable stage III pancreatic cancer.
    Vasile, Enrico
    De Lio, Nelide
    Cappelli, Carla
    Pollina, Luca
    Funel, Niccola
    Sainato, Aldo
    Ginocchi, Laura
    Lucchesi, Maurizio
    Caparello, Chiara
    Caponi, Sara
    Perrone, Vittorio
    Pasqualetti, Francesco
    Caniglia, Fabio
    Signori, Stefano
    Mazzeo, Salvatore
    Greco, Carlo
    Falcone, Alfredo
    Campani, Daniela
    Mosca, Franco
    Boggi, Ugo
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [13] A phase II study of perioperative therapy for patients with resectable and borderline-resectable pancreatic adenocarcinoma.
    Coveler, Andrew L.
    Pillarisetty, Venu Gopal
    Gyurkey, Grace
    Koh, Wui-Jin
    Upton, Melissa
    Cuevas, Carlos
    Gooley, Theodore
    Chiorean, E. Gabriela
    Shankaran, Veena
    Harris, William Proctor
    Park, James Oh
    Mann, Gary N.
    Byrd, David R.
    Balas, Stacey
    Whiting, Samuel H.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [14] Neoadjuvant phase II trial of chemo-radiotherapy (CRT) in patients with resectable (R) and borderline resectable (BR) pancreatic ductal adenocarcinoma (PDA)
    Damarla, V.
    Dobrosotskaya, D.
    Siddiqui, F.
    Wollner, I.
    Raoufi, M.
    Li, J.
    Kwon, D.
    Khan, G.
    EUROPEAN JOURNAL OF CANCER, 2018, 92 : S8 - S9
  • [15] Preoperative modified FOLFIRINOX (mFOLFIRINOX) with or without chemoradiation (CRT) in borderline resectable pancreatic cancer (BRPC): Results from the randomized phase II trial PANDAS/PRODIGE 44
    Lambert, A.
    Bouche, O.
    Ayav, A.
    Bachet, J-B.
    Schwarz, L.
    Piessen, G.
    Vendrely, V.
    Laurent, V.
    Thibaudeau, E.
    Miglianico, L.
    Rinaldi, Y.
    Hammel, P.
    Conroy, T.
    ANNALS OF ONCOLOGY, 2024, 35 : 1252 - 1252
  • [16] Quality of life in a multicenter phase II trial of neoadjuvant full-dose gemcitabine, oxaliplatin, and radiation in patients with resectable or borderline resectable pancreatic adenocarcinoma
    Aybar, Pablo Emilio Serrano
    Herman, Joseph M.
    Zalupski, Mark
    Kim, Edward Jae-Hoon
    Ben-Josef, Edgar
    Bekaii-Saab, Tanios S.
    Wolfgang, Christopher Lee
    Laheru, Daniel A.
    Moore, Malcolm J.
    Dawson, Laura A.
    Ringash, Jolie
    Wei, Alice Chia-chi
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
  • [17] A phase I safety and feasibility study of neoadjuvant chemoradiation plus pembrolizumab followed by consolidation pembrolizumab in resectable stage IIIA non-small cell lung cancer.
    Lemmon, Christopher
    Videtic, Gregory M. M.
    Murthy, Sudish C.
    Stephans, Kevin L.
    Shapiro, Marc A.
    Ahmad, Usman
    Raymond, Daniel
    Velcheti, Vamsidhar
    Bribriesco, Alejandro
    Pennell, Nathan A.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [18] Safety And Tolerability Of Neoadjuvant Chemoradiotherapy Combined With Pembrolizumab For Local Advanced, Resectable Esophageal Cancer: Preliminary Results Of A Prospective Phase IB Trial
    Qi, W. X.
    Zhao, S.
    Li, H.
    Chen, J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E576 - E577
  • [19] Neoadjuvant interferon-based chemoradiation for borderline resectable and locally advanced pancreas cancer: a Phase II pilot study
    Jensen, Eric H.
    Armstrong, Leonard
    Lee, Chung
    Tuttle, Todd M.
    Vickers, Selwyn M.
    Sielaff, Timothy
    Greeno, Edward W.
    HPB, 2014, 16 (02) : 131 - 139
  • [20] Phase I study of veliparib with gemcitabine and radiation therapy in patients with borderline resectable and locally advanced unresectable pancreatic cancer.
    Tuli, Richard
    Nissen, Nicholas N.
    Annamalai, Alagappan
    Hoffman, David M. J.
    Bryant, Miranda
    Tighiouart, Mourad
    Rogatko, Andre
    Rokhsar, Sepehr
    Scher, Kevin S.
    Jamil, Laith
    Lo, Simon
    Hendifar, Andrew Eugene
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
12345